Friedreich Ataxia Drug Market, Global Outlook and Forecast 2022-2028

Friedreich Ataxia Drug Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281664 | No. of Pages: 113 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Friedreich Ataxia Drug in global, including the following market information:
Global Friedreich Ataxia Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Friedreich Ataxia Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Friedreich Ataxia Drug companies in 2021 (%)
The global Friedreich Ataxia Drug market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
ADVM-063 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Friedreich Ataxia Drug include Adverum Biotechnologies Inc, BioMarin Pharmaceutical Inc., Biovista Inc., Cardero Therapeutics Inc, Catabasis Pharmaceuticals, Inc., Forward Pharma A/S, Ixchel Pharma LLC, Pfizer Inc and ProQR Therapeutics NV, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Friedreich Ataxia Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Friedreich Ataxia Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Friedreich Ataxia Drug Market Segment Percentages, by Type, 2021 (%)
    ADVM-063
    AGIL-FA
    BHV-4157
    BVA-202
    Others
Global Friedreich Ataxia Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Friedreich Ataxia Drug Market Segment Percentages, by Application, 2021 (%)
    Clinic
    Hospital
    Others
Global Friedreich Ataxia Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Friedreich Ataxia Drug Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Friedreich Ataxia Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Friedreich Ataxia Drug revenues share in global market, 2021 (%)
Key companies Friedreich Ataxia Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Friedreich Ataxia Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Adverum Biotechnologies Inc
    BioMarin Pharmaceutical Inc.
    Biovista Inc.
    Cardero Therapeutics Inc
    Catabasis Pharmaceuticals, Inc.
    Forward Pharma A/S
    Ixchel Pharma LLC
    Pfizer Inc
    ProQR Therapeutics NV
    RaNA Therapeutics Inc
    Reata Pharmaceuticals Inc
    Retrotope Inc
    Takeda
    STATegics Inc
    Voyager Therapeutics Inc
1 Introduction to Research & Analysis Reports
    1.1 Friedreich Ataxia Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Friedreich Ataxia Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Friedreich Ataxia Drug Overall Market Size
    2.1 Global Friedreich Ataxia Drug Market Size: 2021 VS 2028
    2.2 Global Friedreich Ataxia Drug Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Friedreich Ataxia Drug Sales: 2017-2028
3 Company Landscape
    3.1 Top Friedreich Ataxia Drug Players in Global Market
    3.2 Top Global Friedreich Ataxia Drug Companies Ranked by Revenue
    3.3 Global Friedreich Ataxia Drug Revenue by Companies
    3.4 Global Friedreich Ataxia Drug Sales by Companies
    3.5 Global Friedreich Ataxia Drug Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Friedreich Ataxia Drug Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Friedreich Ataxia Drug Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Friedreich Ataxia Drug Players in Global Market
        3.8.1 List of Global Tier 1 Friedreich Ataxia Drug Companies
        3.8.2 List of Global Tier 2 and Tier 3 Friedreich Ataxia Drug Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Friedreich Ataxia Drug Market Size Markets, 2021 & 2028
        4.1.2 ADVM-063
        4.1.3 AGIL-FA
        4.1.4 BHV-4157
        4.1.5 BVA-202
        4.1.6 Others
    4.2 By Type - Global Friedreich Ataxia Drug Revenue & Forecasts
        4.2.1 By Type - Global Friedreich Ataxia Drug Revenue, 2017-2022
        4.2.2 By Type - Global Friedreich Ataxia Drug Revenue, 2023-2028
        4.2.3 By Type - Global Friedreich Ataxia Drug Revenue Market Share, 2017-2028
    4.3 By Type - Global Friedreich Ataxia Drug Sales & Forecasts
        4.3.1 By Type - Global Friedreich Ataxia Drug Sales, 2017-2022
        4.3.2 By Type - Global Friedreich Ataxia Drug Sales, 2023-2028
        4.3.3 By Type - Global Friedreich Ataxia Drug Sales Market Share, 2017-2028
    4.4 By Type - Global Friedreich Ataxia Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Friedreich Ataxia Drug Market Size, 2021 & 2028
        5.1.2 Clinic
        5.1.3 Hospital
        5.1.4 Others
    5.2 By Application - Global Friedreich Ataxia Drug Revenue & Forecasts
        5.2.1 By Application - Global Friedreich Ataxia Drug Revenue, 2017-2022
        5.2.2 By Application - Global Friedreich Ataxia Drug Revenue, 2023-2028
        5.2.3 By Application - Global Friedreich Ataxia Drug Revenue Market Share, 2017-2028
    5.3 By Application - Global Friedreich Ataxia Drug Sales & Forecasts
        5.3.1 By Application - Global Friedreich Ataxia Drug Sales, 2017-2022
        5.3.2 By Application - Global Friedreich Ataxia Drug Sales, 2023-2028
        5.3.3 By Application - Global Friedreich Ataxia Drug Sales Market Share, 2017-2028
    5.4 By Application - Global Friedreich Ataxia Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Friedreich Ataxia Drug Market Size, 2021 & 2028
    6.2 By Region - Global Friedreich Ataxia Drug Revenue & Forecasts
        6.2.1 By Region - Global Friedreich Ataxia Drug Revenue, 2017-2022
        6.2.2 By Region - Global Friedreich Ataxia Drug Revenue, 2023-2028
        6.2.3 By Region - Global Friedreich Ataxia Drug Revenue Market Share, 2017-2028
    6.3 By Region - Global Friedreich Ataxia Drug Sales & Forecasts
        6.3.1 By Region - Global Friedreich Ataxia Drug Sales, 2017-2022
        6.3.2 By Region - Global Friedreich Ataxia Drug Sales, 2023-2028
        6.3.3 By Region - Global Friedreich Ataxia Drug Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Friedreich Ataxia Drug Revenue, 2017-2028
        6.4.2 By Country - North America Friedreich Ataxia Drug Sales, 2017-2028
        6.4.3 US Friedreich Ataxia Drug Market Size, 2017-2028
        6.4.4 Canada Friedreich Ataxia Drug Market Size, 2017-2028
        6.4.5 Mexico Friedreich Ataxia Drug Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Friedreich Ataxia Drug Revenue, 2017-2028
        6.5.2 By Country - Europe Friedreich Ataxia Drug Sales, 2017-2028
        6.5.3 Germany Friedreich Ataxia Drug Market Size, 2017-2028
        6.5.4 France Friedreich Ataxia Drug Market Size, 2017-2028
        6.5.5 U.K. Friedreich Ataxia Drug Market Size, 2017-2028
        6.5.6 Italy Friedreich Ataxia Drug Market Size, 2017-2028
        6.5.7 Russia Friedreich Ataxia Drug Market Size, 2017-2028
        6.5.8 Nordic Countries Friedreich Ataxia Drug Market Size, 2017-2028
        6.5.9 Benelux Friedreich Ataxia Drug Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Friedreich Ataxia Drug Revenue, 2017-2028
        6.6.2 By Region - Asia Friedreich Ataxia Drug Sales, 2017-2028
        6.6.3 China Friedreich Ataxia Drug Market Size, 2017-2028
        6.6.4 Japan Friedreich Ataxia Drug Market Size, 2017-2028
        6.6.5 South Korea Friedreich Ataxia Drug Market Size, 2017-2028
        6.6.6 Southeast Asia Friedreich Ataxia Drug Market Size, 2017-2028
        6.6.7 India Friedreich Ataxia Drug Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Friedreich Ataxia Drug Revenue, 2017-2028
        6.7.2 By Country - South America Friedreich Ataxia Drug Sales, 2017-2028
        6.7.3 Brazil Friedreich Ataxia Drug Market Size, 2017-2028
        6.7.4 Argentina Friedreich Ataxia Drug Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Friedreich Ataxia Drug Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Friedreich Ataxia Drug Sales, 2017-2028
        6.8.3 Turkey Friedreich Ataxia Drug Market Size, 2017-2028
        6.8.4 Israel Friedreich Ataxia Drug Market Size, 2017-2028
        6.8.5 Saudi Arabia Friedreich Ataxia Drug Market Size, 2017-2028
        6.8.6 UAE Friedreich Ataxia Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Adverum Biotechnologies Inc
        7.1.1 Adverum Biotechnologies Inc Corporate Summary
        7.1.2 Adverum Biotechnologies Inc Business Overview
        7.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Major Product Offerings
        7.1.4 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.1.5 Adverum Biotechnologies Inc Key News
    7.2 BioMarin Pharmaceutical Inc.
        7.2.1 BioMarin Pharmaceutical Inc. Corporate Summary
        7.2.2 BioMarin Pharmaceutical Inc. Business Overview
        7.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Major Product Offerings
        7.2.4 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.2.5 BioMarin Pharmaceutical Inc. Key News
    7.3 Biovista Inc.
        7.3.1 Biovista Inc. Corporate Summary
        7.3.2 Biovista Inc. Business Overview
        7.3.3 Biovista Inc. Friedreich Ataxia Drug Major Product Offerings
        7.3.4 Biovista Inc. Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.3.5 Biovista Inc. Key News
    7.4 Cardero Therapeutics Inc
        7.4.1 Cardero Therapeutics Inc Corporate Summary
        7.4.2 Cardero Therapeutics Inc Business Overview
        7.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Major Product Offerings
        7.4.4 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.4.5 Cardero Therapeutics Inc Key News
    7.5 Catabasis Pharmaceuticals, Inc.
        7.5.1 Catabasis Pharmaceuticals, Inc. Corporate Summary
        7.5.2 Catabasis Pharmaceuticals, Inc. Business Overview
        7.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Major Product Offerings
        7.5.4 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.5.5 Catabasis Pharmaceuticals, Inc. Key News
    7.6 Forward Pharma A/S
        7.6.1 Forward Pharma A/S Corporate Summary
        7.6.2 Forward Pharma A/S Business Overview
        7.6.3 Forward Pharma A/S Friedreich Ataxia Drug Major Product Offerings
        7.6.4 Forward Pharma A/S Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.6.5 Forward Pharma A/S Key News
    7.7 Ixchel Pharma LLC
        7.7.1 Ixchel Pharma LLC Corporate Summary
        7.7.2 Ixchel Pharma LLC Business Overview
        7.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Major Product Offerings
        7.7.4 Ixchel Pharma LLC Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.7.5 Ixchel Pharma LLC Key News
    7.8 Pfizer Inc
        7.8.1 Pfizer Inc Corporate Summary
        7.8.2 Pfizer Inc Business Overview
        7.8.3 Pfizer Inc Friedreich Ataxia Drug Major Product Offerings
        7.8.4 Pfizer Inc Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.8.5 Pfizer Inc Key News
    7.9 ProQR Therapeutics NV
        7.9.1 ProQR Therapeutics NV Corporate Summary
        7.9.2 ProQR Therapeutics NV Business Overview
        7.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Major Product Offerings
        7.9.4 ProQR Therapeutics NV Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.9.5 ProQR Therapeutics NV Key News
    7.10 RaNA Therapeutics Inc
        7.10.1 RaNA Therapeutics Inc Corporate Summary
        7.10.2 RaNA Therapeutics Inc Business Overview
        7.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Major Product Offerings
        7.10.4 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.10.5 RaNA Therapeutics Inc Key News
    7.11 Reata Pharmaceuticals Inc
        7.11.1 Reata Pharmaceuticals Inc Corporate Summary
        7.11.2 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Business Overview
        7.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Major Product Offerings
        7.11.4 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.11.5 Reata Pharmaceuticals Inc Key News
    7.12 Retrotope Inc
        7.12.1 Retrotope Inc Corporate Summary
        7.12.2 Retrotope Inc Friedreich Ataxia Drug Business Overview
        7.12.3 Retrotope Inc Friedreich Ataxia Drug Major Product Offerings
        7.12.4 Retrotope Inc Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.12.5 Retrotope Inc Key News
    7.13 Takeda
        7.13.1 Takeda Corporate Summary
        7.13.2 Takeda Friedreich Ataxia Drug Business Overview
        7.13.3 Takeda Friedreich Ataxia Drug Major Product Offerings
        7.13.4 Takeda Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.13.5 Takeda Key News
    7.14 STATegics Inc
        7.14.1 STATegics Inc Corporate Summary
        7.14.2 STATegics Inc Business Overview
        7.14.3 STATegics Inc Friedreich Ataxia Drug Major Product Offerings
        7.14.4 STATegics Inc Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.14.5 STATegics Inc Key News
    7.15 Voyager Therapeutics Inc
        7.15.1 Voyager Therapeutics Inc Corporate Summary
        7.15.2 Voyager Therapeutics Inc Business Overview
        7.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Major Product Offerings
        7.15.4 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales and Revenue in Global (2017-2022)
        7.15.5 Voyager Therapeutics Inc Key News
8 Global Friedreich Ataxia Drug Production Capacity, Analysis
    8.1 Global Friedreich Ataxia Drug Production Capacity, 2017-2028
    8.2 Friedreich Ataxia Drug Production Capacity of Key Manufacturers in Global Market
    8.3 Global Friedreich Ataxia Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Friedreich Ataxia Drug Supply Chain Analysis
    10.1 Friedreich Ataxia Drug Industry Value Chain
    10.2 Friedreich Ataxia Drug Upstream Market
    10.3 Friedreich Ataxia Drug Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Friedreich Ataxia Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com